[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344689-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344689-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-associated-fibroblasts-in-prostate-cancer-unraveling-mechanisms-and-therapeutic-implications","Cancer-Associated Fibroblasts in Prostate Cancer - Unraveling Mechanisms and Therapeutic Implications","","Prostate cancer (PCa) remains a major cause of cancer-related mortality, driven by therapy resistance and metastatic progression. This review focuses on the tumor microenvironment (TME), emphasizing cancer-associated fibroblasts (CAFs) as key determinants of disease behavior. CAFs are described as a heterogeneous population from multiple cellular origins, showing phenotypic and functional diversity across spatial compartments. The work details how CAFs regulate PCa progression, immune evasion, matrix remodeling, angiogenesis, metabolic reprogramming, and therapeutic resistance, and evaluates emerging strategies. Single-cell and spatial transcriptomics evidence supports a framework for stromal reprogramming as an adjunct to current therapies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-associated-fibroblasts-in-prostate-cancer-unraveling-mechanisms-and-therapeutic-implications/344689/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-associated-fibroblasts-in-prostate-cancer-unraveling-mechanisms-and-therapeutic-implications/344689.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are cancer-associated fibroblasts (CAFs) important in prostate cancer?","Question",{"text":63,"@type":64},"CAFs are emphasized as critical determinants of disease behavior in the prostate tumor microenvironment. Through dynamic interactions, they promote oncogenic processes such as tumor proliferation, invasion, immune evasion, matrix remodeling, angiogenesis, and metabolic reprogramming.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What cellular origins contribute to CAF heterogeneity?",{"text":68,"@type":64},"The review describes CAFs as originating from fibroblasts, mesenchymal stem cells, endothelial cells, epithelial cells undergoing epithelial–mesenchymal transition (EMT), and adipose tissue.",{"name":70,"@type":61,"acceptedAnswer":71},"How do CAFs contribute to therapy resistance and metastatic progression?",{"text":72,"@type":64},"The review explains that CAFs regulate PCa progression and therapeutic resistance by orchestrating signaling and remodeling processes within the TME. It also highlights immune-driven stromal remodeling and epigenetic reprogramming of CAFs that enhance metastatic potential.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344689,1790873013,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Tech Science Press  \n| Doi:10.32604/or.2025.073265\u003Cbr>REVIEW | \u003Cbr>|\n| --- | --- |\n| Cancer-Associated Fibroblasts in Prostate Cancer: Unraveling Mechanisms and Therapeutic Implications\u003Cbr>Yang Wu1, *,\\#, Dong Xu1,\\#, Run Shi1, Mingwei Zhan2, Shaohui Xu3, Xin Wang4, Jianpeng Zhang5, Zhaokai Zhou6, Weizhuo Wang7, Yongjie Wang8, Minglun Li9, Zihao Xu10, * and Kaifeng Su11, *\u003Cbr>1 The First Clinical School, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China\u003Cbr>2 Department of Urology, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Hangzhou, 310007, China\u003Cbr>3 Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, 215123, China 4 Department of Oncology, Jiangsu Cancer Hospital, Nanjing, 210009, China\u003Cbr>5 Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510030, China 6 Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, 410011, China 7 Center for Reproductive Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, 215000, China 8 Proteomics and Cancer Cell Signaling Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany 9 Department of Radiation Oncology, Lueneburg Municipal Hospital, Lueneburg, 21339, Germany\u003Cbr>10 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China\u003Cbr>11 The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250013, China\u003Cbr>*Corresponding Authors: Yang Wu. Email: [surgeonyang@outlook.com](surgeonyang@outlook.com); Zihao Xu. Email: [xuzihao8667@outlook.com](xuzihao8667@outlook.com);\u003Cbr>Kaifeng Su. Email: [kaifeng.su@outlook.com](kaifeng.su@outlook.com)\u003Cbr>\\# These authors contributed equally to this work\u003Cbr>Received: 14 September 2025; Accepted: 14 November 2025; Published: 19 January 2026\u003Cbr>ABSTRACT: Prostate cancer (PCa) remains a major cause of cancer-related mortality in men, largely due to therapy resistance and metastatic progression. Increasing evidence highlights the tumor microenvironment (TME), particularly cancer-associated fibroblasts (CAFs), as a critical determinant of disease behavior. CAFs constitute a heterogeneous population originating from fibroblasts, mesenchymal stem cells, endothelial cells, epithelial cells undergoing epithelial–mesenchymal transition (EMT), and adipose tissue. Through dynamic crosstalk with tumor, immune, endothelial, and adipocyte compartments, CAFs orchestrate oncogenic processes including tumor proliferation, invasion, immune evasion, extracellular matrix remodeling, angiogenesis, and metabolic reprogramming. This review comprehensively summarizes the cellular origins, phenotypic and functional heterogeneity, and spatial distribution of CAFswithin the prostate TME. We further elucidate the molecular mechanisms by which CAFs regulate PCa progression and therapeutic resistance, and critically evaluate emerging strategies to therapeutically target CAFmediated signaling, metabolic, and immune pathways. By integrating recent advances from single-cell and spatial transcriptomics (ST), our objective is to provide a holistic framework for understanding CAF biology and to highlight potential avenues for stromal reprogramming as an adjunct to current PCa therapies.\u003Cbr>KEYWORDS: Prostate cancer; cancer-associated fibroblasts; tumor microenvironment; therapy resistance |  |\n\nCopyright © 2026 The Authors. Published by Tech Science Press.  \nThis work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \n1 Introduction  \nAccording to 2022 estimates by the International Agency for Research on Cancer, prostate cancer (PCa) accounted for 1,466,680 new cases (7.3% of all malignancie","cbCaihjhjkp0RGbl","https://ap.wps.com/l/cbCaihjhjkp0RGbl","pdf",23373656,29,"English","# Abstract\n# Keywords\n# 1 Introduction\n## Epidemiology and risk factors\n## Disease progression and therapy resistance\n## Role of the tumor microenvironment (TME)\n## Immune infiltration and CAF remodeling","[{\"question\":\"Why are cancer-associated fibroblasts (CAFs) important in prostate cancer?\",\"answer\":\"CAFs are emphasized as critical determinants of disease behavior in the prostate tumor microenvironment. Through dynamic interactions, they promote oncogenic processes such as tumor proliferation, invasion, immune evasion, matrix remodeling, angiogenesis, and metabolic reprogramming.\"},{\"question\":\"What cellular origins contribute to CAF heterogeneity?\",\"answer\":\"The review describes CAFs as originating from fibroblasts, mesenchymal stem cells, endothelial cells, epithelial cells undergoing epithelial–mesenchymal transition (EMT), and adipose tissue.\"},{\"question\":\"How do CAFs contribute to therapy resistance and metastatic progression?\",\"answer\":\"The review explains that CAFs regulate PCa progression and therapeutic resistance by orchestrating signaling and remodeling processes within the TME. It also highlights immune-driven stromal remodeling and epigenetic reprogramming of CAFs that enhance metastatic potential.\"}]","Cancer-Associated Fibroblasts in Prostate Cancer - Unraveling Mechanisms and Therapeutic Implications | PDF",1790054939,73,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0d560722869dc9b6a5842d2203b14dc.webp",983,1271,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb6cb7fc34b9d3d6d113e28b73623867.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdf2374b75b0502128e2873c4031a909.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f46bf70e2cfa3ac551fed20604dfee3.webp",980,1267]